Objective: Calcific aortic valve disease (CAVD) is a major cause of aortic stenosis (AS) and cardiac insufficiency. Patients with type II diabetes mellitus (T2DM) are at heightened risk for CAVD, and their valves have greater calcification than nondiabetic valves. No drugs to prevent or treat CAVD exist, and animal models that might help identify therapeutic targets are sorely lacking. To develop an animal model mimicking the structural and functional features of CAVD in people with T2DM, we tested a diabetogenic, procalcific diet and its effect on the incidence and severity of CAVD and AS in the, LDLr -/-ApoB 100/100 mouse model. ApoB 100/100 that shows several important functional, and structural features similar to CAVD found in people with T2DM and atherosclerosis including AS, cardiac dysfunction, and inflamed and calcified thickened valve cusps. Importantly, the high AS incidence of this diabetic model may be useful for mechanistic and translational studies aimed at development of novel treatments for CAVD.
Introduction
Calcific aortic valve disease (CAVD) is the underlining pathology leading to the clinical manifestation of aortic stenosis (AS), which can lead to heart failure and death if untreated [1] . CAVD is characterized by the accumulation, over time, of calcium-phosphate nodules within the fibrous matrix of the aortic valve leaflets resulting in a dysfunctional and narrowed valve opening. As CAVD is a progressive disease, patients are frequently free of symptoms for several decades, however~30% of the aging population is affected with aortic sclerosis that is the early asymptomatic manifestation of the disease. A smaller group of this population will progress to the symptomatic AS,~2% by age 65 and~4% by age 85. CAVD accounts for 50% of cardiac valve disease and is the third most common cardiovascular disease following coronary disease and hypertension [2, 3] . In symptomatic CAVD patients, the narrowed valve opening results in obstruction of left ventricular outflow, reduced cardiac output, and increased blood velocity through the valve opening eventually leading to left ventricular dysfunction and heart failure [4, 5] .
CAVD risk factors include congenital malformation, age, male sex, smoking, hypercholesterolemia, hypertension, and diabetes mellitus [6] . Patients with type II diabetic mellitus (T2DM) not only have a heightened risk for CAVD but also a significantly increased "new" incidence compared to those without [7, 8] . In addition, Nishimura et al. have recently reported that diabetes and moderate/severe calcification score at diagnosis predicted first year rapid progression [9] . Metabolic syndrome was also associated with faster disease progression and worse outcome in patients with AS [10] . At the tissue level, histopathological assessment showed greater calcification in diseased aortic valves from T2DM patients compared to nondiabetic patients [11] .
To date, there are no pharmacological treatments available to reverse or retard the progression of CAVD. Traditional cardiovascular drugs like cholesterol-lowering therapies (statins) and reninangiotensin system blocking drugs have been the major pharmacological agents under active investigation in clinical trials, but have proven to be unsuccessful in slowing the progression of CAVD [12] [13] [14] [15] . These findings imply that despite the similarity in risk factors between vascular and valvular disease and the coexistence of CAVD and cardiovascular disease in patients, different mechanisms underlie their development and progression [16] [17] [18] . Thus, as there is no effective drug therapy for CAVD, AS is the second most common indication for cardiac surgery. Surgical methods to repair or replace the aortic valve include open-heart or transcatheter aortic valve replacement [19] . Both are associated with risk of adverse events and substantial healthcare costs [4] . Given that the burden of diabetes and CAVD will continue to increase worldwide in the coming decade, a pharmacological method to reverse or slow the progression of CAVD is greatly needed.
Part of the reason for the lack of therapies to treat CAVD in diabetes is the paucity of animal models mimicking the structural and functional features of human diabetic CAVD. Structurally human diseased valve leaflets show severe fibrosis, calcific nodules, neoangiogenesis, inflammation, bone metaplasia with or without hematopoiesis, adipose metaplasia, and cartilaginous metaplasia [20] . Further, valve leaflets derived from diabetic patients have statistically more calcium nodules and overall calcification [11] . In the present study, we report the development of a new mouse model of lipid-driven, diabetic CAVD that recapitulates the functional features of CAVD found in patients as well several of the structural features of human diseased valve leaflets including fibrosis, calcification deposits, inflammation and cartilaginous metaplasia. To achieve this we used the atherosclerosis prone LDLr -/-:ApoB 100/100 mice that when fed a custom diabetogenic procalcific (DB) diet developed T2DM and metabolic syndrome, high incidence of CAVD characterized by more calcium deposits on the valve leaflets than control diet mice, and had a higher incidence of hemodynamically significant AS than any diet induced animal models to date. Finally, left ventricular function of these mice was also diminished [21] . This new diet and genetic model combination should aid in testing new mechanistic hypotheses regulating CAVD in diabetes and therapies in general.
Material and Methods

Animals
Male LDLr -/-:ApoB 100/100 male mice, 10-12 weeks old (≥20g), were randomly assigned to two groups fed either a diabetogenic, procalcific diet (DB; Bio-Serv., 1.25% cholesterol, 57.5% kcal fat, 27.4% kcal carbohydrate) [21] to induce CAVD or normal chow (NC) as dietary control. Body weight and fasted blood glucose levels were recorded before challenging with the diets and every five weeks until 20 weeks of diet. A total of 13 mice per group were used for echocardiography and histological analysis of aortic valves. Mice were euthanized via intraperitoneal injection of pentobarbital (150 mg/kg) followed by exsanguination through cardiac puncture to collect sera. All animals were maintained in a specific pathogen-free environment and genotypes were determined as described [21, 22] . All protocols are in compliance with the NIH Guideline for the Care and Use of Laboratory Animals and have been approved by the Institutional Animal Care and Use Committee, University of Washington.
Echocardiography
Transthoracic echocardiography was performed in isoflurane anesthetized mice with a heart rate of~450-500 beats/min using high-resolution in vivo ultrasound imaging system for small animals equipped with a 40-MHz transducer (Vevo 2100 TM , VisualSonics Inc.). Aortic valve function was assessed using Pulse Wave Doppler-mode that measures aortic valve peak velocity and gradient. In brief, Doppler flow velocity spectrum of the ascending aorta of each mouse was recorded at three locations, the anterior, middle, and posterior parts of the aortic lumen. A minimum of three cardiac cycles at each location were traced to obtain an average for aortic peak velocity and gradient using Vevo 2100 TM software. Images were taken from the upper right parasternal long axis view and the angle of the transducer was maintained at 55 degree. B-mode and M-mode images of the parasternal long axis and short axis views were used to measure left ventricular dimensions and volumes, fractional shortening, and ejection fraction. The cardiac package provided by VisualSonic was used to measure and calculate several parameters including the aortic jet Characterization of LDLr−/−ApoB100/100 mice fed a customized type 2 diabetes mellitus inducing procalcific diet. LDLr−/−ApoB100/100 mice were challenged with a customized type 2 diabetes mellitus inducing procalcific (DB) and a control normal chow (NC) diet. T2DM development was monitored by blood glucose level (A) and body weight (B). Data are normally distributed. Data were analyzed by two-way ANOVA with repeated measure and Bonferroni's test, Mean ± S.E.M., n=8-13. *pb0.001 DB vs. NC for both glucose and body weight. velocity and the mean gradient. The aortic valve area (AVA) was calculated with the continuity equation [23, 24] .
Serum Analyses
Sera were collected with serum separator tubes and analyzed for cholesterol, triglyceride and phosphate levels via bioanalyzer. Calcium levels were determined colorimetrically using the o-Cresolphthalein complexone kit (Teco Diagnostics, C503-480) as previously described. 36 Blood urea nitrogen (BUN) was measured using QuantiChrom Urea Assay Kit (BioAssay System, DIUR-500) [25] .
Histochemical and Immunohistochemical Staining
LDLr -/-:ApoB 100/100 mice were perfused fix and hearts were post-fixed with modified 10% formalin prior to processing and embedding in paraffin. Serial sections were made in 5 μm thickness and subject to various histochemical and immunohistochemical staining. Alizarin red S and Osteosense were used to visualize calcium deposition. Movat pentachrome staining was used to visualize atherosclerotic lesion and cartilaginous metaplasia and Picrosirus Red was used to visualize collagen [26] .
Morphometric Analysis of Aortic Roots
To measure aortic valve leaflet size and sinus lesion size, four cross sections, 80 μm apart over 320 μm in depth, starting at the appearance of three valve leaflets, were collected from each aortic root. Sections were stained using the Movat pentachrome method, and aortic sinus lesion area and valve leaflet area were measured blindly and normalized to the cross sectional area of aortic root using NIS elements software (Nikon) [26] [27] [28] . To assess calcium deposition Osteosense positive areas were visualized fluorescently using the same sampling scheme, and determined morphometrically as percentage of the total areas measured [26] .
Baboon VIC Calcium Assay
Non-human primate baboon VICs (BVICs) were generated and characterized as previously described [29] Approximately 40,000 cells were seeded in each well of 12-well plates and cultured in DMEM culture medium containing 5% (v/v) fetal bovine serum (FBS) and 100 U/ mL penicillin/streptomycin (normal medium) or calcification medium (normal medium supplemented with inorganic phosphate to a final concentration of 2.6 mM) to induce calcification. After five days, cells were rinsed with PBS and decalcified with 0.6 mmol/L HCl at 4°C for 24 hours. Levels of calcium released from cell cultures were determined colorimetrically by the o-cresolphthalein complexone method as previously described (Teco Diagnostics, C503-480) [30] . Calcium amount was normalized to cellular protein of the culture and expressed as μg/mg cellular protein.
Statistics
Normality of distribution was assessed with Shapiro-Wilk normality test. Normally distributed data are shown as means ± S.E.M., and were analyzed with Student's t-test for comparison of 2 groups, and one-way ANOVA with Dunnett's test and two-way ANOVA with Bonferroni's test for comparison of multiple groups. Data that were not normally distributed were analyzed with Mann-Whitney U test. Data are considered statistically significant at a p value b 0.05.
Results
Diabetogenic diet-feeding induces symptoms of T2DM in LDLr-/-ApoB100/100 mice
To induce T2DM, LDLr-/-ApoB100/100 mice were fed a well characterized diabetogenic, procalcific (DB) diet [21] . As shown in Fig. 1A , blood glucose levels increased steadily and significantly in mice fed the DB diet when compared to normal chow (NC) fed LDLr-/-ApoB100/100 mice. Likewise, mice fed the DB diet showed a significant and steady increase in body weight (Fig. 1B) . At 7 months of age DB fed mice were significantly heavier than NC fed, however, at 14 months there was no significant difference in weight between the two groups. As expected, blood cholesterol and triglycerides levels were elevated in DB fed mice compared to NC fed at 14 months of age. Phosphate and calcium serum levels were slightly but significantly elevated in the DB fed group, however, there was no significant difference in urea nitrogen levels, indicating normal renal function (Table 1) .
DB fed mice have impaired Aortic Valve Function
To assess whether the DB diet affected aortic valve function and the development of AS, we performed hemodynamic echocardiography. At 14 months of age, LDLr-/-ApoB100/100 mice DB fed showed a significantly greater proportion of AS than NC fed mice, as indicated by aortic jet velocities greater than 1600 mm/s (10/13=77% versus 5/13=38%, respectively, p=.048) ( Fig. 2A and B) . The 1600 mm/s cut-off value was chosen as it represents a doubling of the aortic jet velocity in WT mice fed normal chow (~8000 mm/s) [31] ; this is consistent with clinically established parameters for human severe AS [23] . Further and importantly, the mean gradient was significantly greater and the stenotic orifice area or aortic valve area (AVA) was significantly smaller in DB vs NC fed mice (Fig. 2C and D) . Finally, cardiac muscle function parameters were also affected by the DB diet. Both the ejection fraction and the fractional shorting trended lower in DB fed compared to NC fed mice (Fig 3A and B and B mode and M mode example tracing in Fig. 4) . Further, when only mice with AS (aortic jet velocityN 1600 mm/s) were analyzed as a subgroup, both ejection fraction and fractional shortening were significantly impaired in DB fed compared to the NC fed animals ( Fig. 3C and D) .
3.3. DB fed mice have thicker and more calcified aortic valve leaflets and sinus lesions than NC mice.
We next performed histological analyses to determine aortic valve leaflet morphology and calcification. Movat Pentacrome staining of the aortic sinus region revealed that 14 month-old LDLr-/-ApoB100/100 mice fed the DB diet had significantly thicker valve leaflets than NC fed mice (Fig. 5A-C ). As expected, DB feeding also induced larger atherosclerotic lesions than NC feeding (Fig. 5D) . Osteosense stained aortic sinus sections revealed that DB diet fed mice had significantly more calcium deposits associated with the valve leaflets and the atherosclerotic lesions ( Fig. 6A and B, asterisks) . Further analyses revealed extensive collagen deposition in the leaflets of mice fed either diet (Fig. 7A  and B) . Further, staining for macrophages showed widespread macrophage accumulation in the thickened, calcified leaflets of DB fed mice ( Fig. 7C and D) . Detailed histological analysis of DB fed mice showed the presence of chondrocyte-like cells in the collagen-rich hinge areas as well as in the collagen-and proteoglycan-rich areas of the valve leaflets (Fig. 8A , B, D and E). Calcium deposits were found in the collagen-rich hinge areas and in the proteoglycan-and collagen-rich areas of the valve leaflets ( Fig. 8 C and F) . As shown in Fig. 7 , calcium deposits were also found in the atherosclerotic lesion ( Fig. 8C and F) . These results suggest that the elevated incidence of AS in DB fed mice are likely to result from the structural changes observed at the tissue level.
Higher Glucose levels enhance Valve Interstitial Cell mineralization
We next examined whether elevated glucose levels, similar to those observed in T2DM, could directly regulate valve interstitial cell (VIC) calcification in vitro. We used a well-characterized in vitro calcification assay whereby cells are cultured in calcification medium containing elevated inorganic phosphate to induce matrix mineralization. Baboon VICs were cultured in normal medium containing 1.0 mM inorganic phosphate and in calcification medium containing 2.6 mM inorganic phosphate in the presence of 5% fetal bovine serum. As shown in Fig. 9 , the calcification medium induced VICs mineralization after 5 and 7 days of culture. Addition of 25 mM glucose (hyperglycemic level) to the calcification medium enhanced VIC mineralization by~2 folds compared to 5.6 mM glucose cultures. No effect of glucose was found in VIC grown in normal media.
Discussion
T2DM has been associated with faster progression to symptomatic AS in patients with CAVD [1-3,32-35]. Here we have developed a diabetic mouse model of CAVD with increased severity of valve calcification and accelerated progression to AS. This model provides researchers with a new tool to address the mechanisms of CAVD and AS, particularly in the setting of T2DM.
Our new model builds on the LDLr-/-ApoB100/100 CAVD mouse model, originally described by the Heistad group [33] [34] [35] . As reported by those investigators, about 50% of 20 month old LDLr-/-ApoB100/100 mice fed a western diet developed measurable AS evidenced by reduced cusp separation, reduced systolic valve orifice and increased aortic peak gradient. In these studies, Hiestad and colleagues examined the role of hyperlipidemia in the development of CAVD and AS. They indeed showed that the western diet induced mineralization of the valve cusps as well as acquisition of osteochondrogenic and oxidative signaling. When hyperlipidemia was reduced in the LDLr-/-ApoB100/100 "Reversa" mouse the osteochondrogenic signaling was dampened, however the valve function was not rescued [33] . These results are well aligned with the clinical finding that lipid lowering drugs (statins) do not ameliorate the severity of AS in humans [14, 15] . However, how T2DM and metabolic syndrome further contribute to worsen CAVD and AS and by which mechanisms remain unexplored and in need of new models and tools. To determine whether T2DM exacerbated the severity of CAVD and progression to AS in LDLr-/-ApoB100/100, we used a previously characterized diabetogenic and procalcific diet (DB diet). This diet has been shown to induce T2DM with features of metabolic syndrome, as shown by hyperglycemia, hyperinsulinemia, hypercholesterolemia and obesity. Further, this diet induced extensive cartilaginous metaplasia and mineralization of the atherosclerotic arteries and it was found that insulin resistance positively correlated with the extent of calcification [21] . Using clinically recommended hemodynamic parameters for the assessment of AS [23, 24] , we found that 77% of the LDLr-/-ApoB100/100 mice fed the DB diet for 12 months developed severe AS, compared to 38% of the mice fed the NC diet. Le Quang et al. have reported similar results using a genetic model in which plasma glucose elevation was obtained by overexpression of the insulin-like grow factor II in the LDLr-/-ApoB100/100 background, thus confirming that superimposition of hyperlipidemia and diabetes accelerate AS progression [36] . However, the LDLr-/-ApoB100/100 IGFII model entails an additional genetic manipulation which is not necessary with our DB diet induced T2DM model. We further observed that when only animals on either the DB or NC diet with aortic jet velocity above 1600 mm/s were analyzed for heart functional parameters, the DB fed mice showed decreased ejection fraction and fractional shortening indicating acceleration of myocardium deterioration and suggesting an earlier onset of AS and CAVD in the DB diet fed mice.
Clinically, the failure of the aortic valve function in severe AS correlates with thickened, fibrotic, calcified and inflamed aortic valve leaflets [2] . We thus assessed and quantified these parameters in our model by histology. As this is a hyperlipidemic model, we also determined the extent of the atherosclerotic lesion in the aortic sinus. Thus, we measured the atherosclerotic lesion and the aortic valve leaflets areas and morphometrically quantified the leaflet thickness and the atherosclerotic lesion size separately. To our knowledge this is the first quantification of leaflet thickness in the LDLr-/-ApoB100/100 model of AS in response to a diabetogenic diet. As predicted the DB diet induced thickening of the leaflets in DB LDLr-/-ApoB100/100 fed mice when compared to NC fed. These results confirm and expand observations by Drolet et al. that showed that a high fat diet induced leaflet thickening in wild type mice [31] . We also performed a similar quantification on sections stained for mineral by using Osteosense 680 EX, a fluorescent in vivo bisphosphonate imaging agent that binds calcium. This staining modality was chosen for its the low background and the fluorescent properties as Alizarin Red and Von Kossa stains often results in high background or a black color that can be confused with the population of melanocytes found in rodent heart valves [37] . Osteosense quantifications confirmed the hypothesis that the DB diet promoted mineralization of the leaflets thus correlating with the severity of AS. Further, as we have previously shown in the LDLr-/-model of atherosclerosis, the DB diet also induced larger and more mineralized atherosclerotic lesions. These results differ slightly from the LDLr-/-ApoB100/100 IGF II model where the atherosclerotic lesions were found to mineralize more than controls but there was no significant increase in lesion size [36, 38] . Hyperlipedimia in familial hypercholesterolemia patients has been shown to correlate with premature valvulopathy of the aortic valve and atherosclerosis of the aorta [39] . Further, other studies show that AS patients have significantly higher rates of aortic atherosclerosis [16, 18] . These data indicate that the coexistence of CAVD and atherosclerosis in the lipid-driven inflammatory LDLr-/-ApoB100/100 diabetic model mimics the pathological presentation of the disease in at least a subset of AS patients and may aid researchers in determining the mechanisms differentially regulating the two diseases. However, this model may not simulate the human CAVD that develops in the absence of diabetes and hyperlipidemia, for example, in valvulopathy associated with rheumatic fever or bicuspid aortic valve. While sharing some common pathological features like inflammation, fibrosis and calcification, these diseases may have very different etiology and pathobiology, thus necessitating new experimental model development.
We also performed detailed histological studies to address collagen, proteoglycan, calcium deposition and inflammation in DB fed mice. The leaflets were rich in collagen and proteoglycan while the hinge areas were mostly composed of dense collagen as shown by trichrome staining (Fig. 8B) . The presence of chondrocyte cells and calcium deposits in the hinge areas and valve leaflets support the notion of VICs undergoing osteochondrogenic differentiation and active mineral deposition processes rather than passive mineralization. These features mimic some of the histological characteristic of diseased human cusps, however we did not observe neoangiogenesis, very large calcified nodules, and bone metaplasia. This is probably due to the differences in the tissue between the two species. Indeed, human valve like human arteries are much larger than rodent's and necessitate tissue vascularization as diffusion from the surrounding blood is not sufficient for tissue survival. Further, the lack of large nodules and bone metaplasia may mimic an earlier stage of human CAVD. Nonetheless, as discussed above the function of the aortic valve in these mice is compromised despite the lack of large calcifying nodules protruding the lumen of the aorta. We also found abundant macrophages present in the leaflets that mostly accumulate on the aortic side of the valve of the DB fed mice. These finding suggest that inflammation may be one of the drivers of the fibrocalcific process in valve leaflets in LDLr-/-ApoB100/100 fed the DB diet. Indeed, it has been proposed that inflammation and activated macrophages may be releasing pro-calcification factors promoting the valve interstitial cell to become osteogenic, to deposit calcium and eventually to mineralize [40] . Further, inflammation and macrophage accumulation are well known components of diabetic atherosclerosis and vascular Extensive calcification in the leaflets (**, C and F) is associated with collagen and proteoglycan rich areas. Extensive calcification is also present in the atherosclerotic lesion (AL) (*, C and F) associated with collagen and proteoglycan rich areas. Chondrocyte-like cells are also present in the leaflets and hinge areas (orange arrows, D and E). Melanocytes (black arrows, F) are present in the leaflets. AL=atherosclerotic lesion areas, **=leaflet calcification, *=atherosclerotic lesion calcification, arrow-head=calcification and chondrocyte cells in the hinge areas, orange arrows=chondrocyte-like cells.
calcification [41] . The contribution of inflammatory macrophages to the induction of leaflet thickening and increased mineralization in this diabetic model warrants further studies. As new drug targets are needed, the precise mechanisms of diabetes as an accelerator of valvular and vascular calcification are currently under intense investigation. In diabetic accelerated atherosclerosis the interaction of advanced glycation end-products (AGEs), a nonenzymatic glycosylation of proteins and lipids under hyperglycemia, with RAGE, a multiligand receptor that interacts with AGEs and other ligands has been shown to contribute to the exacerbation of the disease. Further, AGEs have been found to induce osteogenic differentiation in vascular smooth muscle cells [42] . Additional studies also indicate that high level of glucose stimulate the mineralization capacity of vascular smooth muscle cells and their expression of osteogenic genes [43] [44] [45] . Here for the first time, we show that VICs in vitro respond directly to elevated glucose with enhanced mineralization. These results may suggest a new mechanism behind the diabetes-dependent acceleration of valve mineralization.
In summary, with these studies we have established a new diet-induced model of diabetic CAVD and AS with functional and several structural features mimicking the human disease. Patients with T2DM not only have a heightened risk for CAVD but also a significantly increased "new" incidence compared to those without and the level of aortic valve calcification at diagnosis is highly associated with rate of AS progression [7] [8] [9] . Thus, as LDLr-/-ApoB100/100 DB fed mice show acceleration of the CAVD and AS compared to NC fed mice the model developed here provides a new tool to address the molecular mechanisms of diabetic CAVD. 
